Signal active
Organization
Contact Information
Overview
Transcripta Bio is a company dedicated to drug discovery, with a focus on numerous diseases at once, at a never-before-seen pace and scale, with lesser risk and greater assurance.
About
Biotechnology, Medical
2020
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Transcripta Bio headquartered in United States, North America, operates in the Biotechnology, Medical sector. The company focuses on Biotechnology and has secured $80.0M in funding across 8 round(s). With a team of 11-50 employees, Transcripta Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Transcripta Bio, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
1
2
0
$10.0M
Details
0
Transcripta Bio has raised a total of $10.0M in funding over 0 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|
Investors
Transcripta Bio is funded by 3 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Jazz Venture Partners | - | FUNDING ROUND - Jazz Venture Partners | 10.0M |
Transcripta Bio | - | FUNDING ROUND - Transcripta Bio | 10.0M |
BlueYard Capital | - | FUNDING ROUND - BlueYard Capital | 10.0M |
Recent Activity
There is no recent news or activity for this profile.